Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer

Published:2019-08-28 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kalscheuer Stephen,Khanna Vidhi,Kim Hyunjoon,Li Sihan,Sachdev Deepali,DeCarlo Arthur,Yang Da^ORCID,Panyam Jayanth^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering

Community of Pharmaceutical Development (CPD), Office of Discovery and Translation (ODAT) at the University of Minnesota, the Randy Shaver Foundation

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-48993-6.pdf

Reference53 articles.

1. Sawka, C. A. et al. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence. Clin. Cancer Res. 13, 4429–4434 (2007).

2. Burstein, M. D. et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin. Cancer Res. 21, 1688–1698 (2015).

3. Balko, J. M. et al. Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov. 4, 232–245 (2014).

4. Turner, N. et al. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 29, 2013–2023 (2010).

5. Corkery, B., Crown, J., Clynes, M. & O’Donovan, N. Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer. Ann. Oncol. 20, 862–867 (2009).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dimension reduction, cell clustering, and cell–cell communication inference for single-cell transcriptomics with DcjComm;Genome Biology;2024-09-09

2. Tunable Hybrid Hydrogels of Alginate and Cell‐Derived dECM to Study the Impact of Matrix Alterations on Epithelial‐to‐Mesenchymal Transition;Advanced Healthcare Materials;2024-09-09

3. Human-derived Tumor-On-Chip model to study the heterogeneity of breast cancer tissue;Biomaterials Advances;2024-09

4. FOXO3 suppresses lymphoma progression through promoting miR‐34b/HSPG2 axis;International Journal of Laboratory Hematology;2024-05-22

5. Proteoglycans in mechanobiology of tissues and organs: Normal functions and mechanopathology;Proteoglycan Research;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3